Evaluation of Indomethacin and Tadalafil Supersaturation in an In Situ Rat Intestinal Perfusion Model

Sophie Strindberg Andersen, Line Hagner Nielsen, Martin Lau Christiansen, Thomas Rades, Anette Müllertz

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

72 Downloads (Pure)

Original language	English
Publication date	2018
Publication status	Published - 2018
Event	11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology - Granada, Spain Duration: 19 Mar 2018 → 22 Mar 2018 Conference number: 11

Conference	11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
Number	11
Country/Territory	Spain
City	Granada
Period	19/03/2018 → 22/03/2018

Access to Document

@conference{d684eb9ab89247f282c4949ad8a11ce6,

title = "Evaluation of Indomethacin and Tadalafil Supersaturation in an In Situ Rat Intestinal Perfusion Model",

author = "Andersen, {Sophie Strindberg} and Nielsen, {Line Hagner} and Christiansen, {Martin Lau} and Thomas Rades and Anette M{\"u}llertz",

year = "2018",

language = "English",

note = "11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology ; Conference date: 19-03-2018 Through 22-03-2018",

}

Evaluation of Indomethacin and Tadalafil Supersaturation in an In Situ Rat Intestinal Perfusion Model. / Andersen, Sophie Strindberg; Nielsen, Line Hagner; Christiansen, Martin Lau et al.
2018. Abstract from 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Granada, Spain.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

TY - ABST

T1 - Evaluation of Indomethacin and Tadalafil Supersaturation in an In Situ Rat Intestinal Perfusion Model

AU - Andersen, Sophie Strindberg

AU - Nielsen, Line Hagner

AU - Christiansen, Martin Lau

AU - Rades, Thomas

AU - Müllertz, Anette

N1 - Conference code: 11

PY - 2018

Y1 - 2018

M3 - Conference abstract for conference

T2 - 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

Y2 - 19 March 2018 through 22 March 2018

ER -